Park Square Financial Group’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Park Square Financial Group’s Portfolio FMED Stock Details FMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-589	Closed	-$14.1K	–	507
2025 Q2	$14.1K	Hold	589	–	–	0.01%	532
2025 Q1	$13.9K	Hold	589	–	–	0.01%	527
2024 Q4	$14.5K	Buy	+589	New	+$15.2K	0.01%	505

Other funds holding FMED

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

GJIA

Glass Jacobson Investment Advisors Owings Mills, Maryland $321M AUM 20.69% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CPBTD

Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return

GEA

Glen Eagle Advisors Kingston, New Jersey $714M AUM 18.87% 1-Year Est. Return

Park Square Financial Group's FMED Position: Q3 2025 in Review

Park Square Financial Group sold out of Fidelity Disruptive Medicine ETF (FMED) in Q3 2025, closing a stake of 589 shares — an estimated $14.1K sold.

Park Square Financial Group first reported a position in FMED in Q4 2024 and held it in 3 quarters. The position peaked at $14.5K in Q4 2024. 7 funds tracked by Wall St. Rank hold FMED as of Q3 2025.

Park Square Financial Group reported no remaining Fidelity Disruptive Medicine ETF position as of Q3 2025 after selling out during the quarter.
Park Square Financial Group sold 589 Fidelity Disruptive Medicine ETF shares in Q3 2025, an estimated $14.1K.
Park Square Financial Group first reported a position in Fidelity Disruptive Medicine ETF in Q4 2024 and held it in 3 quarters.
Park Square Financial Group's Fidelity Disruptive Medicine ETF position peaked at $14.5K in Q4 2024.
7 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q3 2025.

Based on Park Square Financial Group's 13F filing for Q3 2025, filed 12 Nov 2025.